Depression and peripheral inflammatory profile of patients with obesity
| Autor: | Débora Kurrle Rieger, Ana Lúcia S. Rodrigues, Fernanda Neutzling Kaufmann, Gabriela Ambrósio, Manuella P. Kaster, Luana M. Manosso, Gabriele Ghisleni, Nicolle Platt |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Adult
Male medicine.medical_specialty Endocrinology Diabetes and Metabolism Inflammation Overweight Body Mass Index 03 medical and health sciences 0302 clinical medicine Endocrinology Weight loss Internal medicine medicine Humans In patient Obesity Biological Psychiatry Depression (differential diagnoses) Depressive Disorder Depression Interleukin-6 Endocrine and Autonomic Systems business.industry Middle Aged medicine.disease 030227 psychiatry Peripheral Psychiatry and Mental health C-Reactive Protein Cross-Sectional Studies Female medicine.symptom business Body mass index Biomarkers 030217 neurology & neurosurgery |
| Zdroj: | Psychoneuroendocrinology. 91:132-141 |
| ISSN: | 0306-4530 |
| DOI: | 10.1016/j.psyneuen.2018.03.005 |
| Popis: | This narrative review will present and discuss clinical data from 16 cross-sectional and 6 longitudinal studies examining the relationship between body mass index (BMI), symptoms of depression and peripheral inflammation. Our aim is to determine which of obesity and depression contributes best to the peripheral low-grade inflammation frequently associated to both conditions. Studies including a complete evaluation of inflammatory markers are scarce and high levels of interleukin-6 (IL-6) and C-reactive protein (CRP) are the most consistent findings associated with obesity and symptoms of depression. Among the cross-sectional studies, seven studies, including a total of 9421 individuals, pointed to BMI as the major factor associated with systemic low-grade inflammation. However, in four studies, including 16,837 individuals, CRP levels remained associated with the symptoms of depression even after correction for BMI, suggestion that in the absence of overweight or obesity other sources of peripheral inflammation might contribute to presence of depressive symptoms. Additionally, another five studies, including 5569 individuals failed to find an association between depression and peripheral inflammation, reinforcing the heterogeneity of this condition. In the longitudinal data, changes in BMI were associated with a reduction in depressive scores at follow-up, after bariatric surgery or after diet. In four longitudinal studies, high levels of CRP were found to be associated with depression even after adjustment for BMI and weight loss, further corroborating the idea that other sources of peripheral inflammation might contribute to depressive symptoms. Thus it seems that both obesity and depressive symptoms can contribute to peripheral inflammation, and once installed the presence of inflammation can contribute to several behavioral alterations that reinforce the cyclic pattern of co-occurrence observed in patients with obesity and MDD. Future clinical studies should focus on strategic efforts to collect new data and to improve or standardize methods for the evaluation of depression, body composition and a more complete inflammatory profile. These approaches are essential for the development of pharmacological and/or non-pharmacological strategies designed to break this cyclic pattern of co-occurrence. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect